For the quarter ending 2025-09-30, PULM had -$1,031K decrease in cash & cash equivalents over the period. -$1,031K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Purchases of property and equipment | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Depreciation and amortization | 0 | 0 |
| Amortization of operating lease right-of-use asset | 0 | 0 |
| Loss on mannkind transaction | 0 | 0 |
| Accounts receivable | 0 | 0 |
| Operating lease liability | 0 | 0 |
| Deferred revenue | 0 | 0 |
| Net loss | -877 | -3,357 |
| Stock-based compensation | 6 | 14 |
| Fair value adjustment of warrants | 0 | -67 |
| Prepaid expenses and other current assets | -139 | -82 |
| Other long-term assets | 0 | -13 |
| Accounts payable | -315 | -425 |
| Accrued expenses and other current liabilities | 16 | 44 |
| Net cash used in operating activities | -1,031 | -3,696 |
| Net decrease in cash, cash equivalents and restricted cash | -1,031 | -3,696 |
| Cash and cash equivalents at beginning of period | 9,531 | - |
| Cash and cash equivalents at end of period | 4,804 | - |
Pulmatrix, Inc. (PULM)
Pulmatrix, Inc. (PULM)